Background: Etomidate is the standard induction agent used during rapid sequence intubation (RSI) in the emergency department (ED). Etomidate shortages require providers to utilize alternative agents. The purpose of this study is to compare the safety and procedural outcomes of propofol and etomidate for RSI in the ED. Methods: This was a retrospective chart review of adult patients in the ED who received propofol or etomidate for induction during RSI. The main endpoint was hypotension, defined as a systolic blood pressure < 90 mmHg or diastolic blood pressure < 60 mmHg, within the first hour of intubation. Time to intubation, intensive care unit length of stay, hospital length of stay, and in-hospital mortality were also evaluated. Results: Two hundred and seventy five patient charts were reviewed. Of the 98 patients included, 43 patients received propofol and 55 patients received etomidate. Propofol was associated with an increased incidence of hypotension within the first hour of intubation (65.1% vs. 25.5%, p < 0.001). No difference was found in the time to intubation: ≤5 minutes (51.2% vs. 34.6%, p = 0.83). The mortality rate was 11.6% in the propofol group and 27.3% in the etomidate group (p = 0.004). There was no difference in hospital or intensive care unit length of stay between the propofol and etomidate groups (7.7 vs. 9.2 days, p = 0.23; 4.2 vs. 6.3 days, p = 0.31). Conclusion: Propofol was a safe and procedurally effective induction agent for RSI. Compared to etomidate, it was associated with an increased rate of hypotension within the first hour of intubation, with no difference in the percent of patients that required an intervention.
References
[1]
Mace, E. (2008) Challenges and Advances in Intubation: Rapid Sequence Intubation. Emergency Medicine Clinics of North Americ, 26, 1043-1068.
https://doi.org/10.1016/j.emc.2008.10.002
[2]
Hampton, J.P. (2011) Rapid-Sequence Intubation and the Role of the Emergency Department Pharmacist. American Journal of Health-System Pharmacy, 68, 1320-1330. https://doi.org/10.2146/ajhp100437
[3]
Skinner, H.J., Biswas, A. and Mahajan, R.P. (1998) Evaluation of Intubating Conditions with Rocuronium and Either Propofol Or Etomidate for Rapid Sequence Induction. Anaesthesia, 53, 702-706.
https://doi.org/10.1046/j.1365-2044.1998.396-az0506.x
[4]
Mallon, W.K., Keim, S.M., Shoenberger, J.M. and Walls, R.M. (2009) Rocuronium vs. Succinylcholine in the Emergency Department: A Critical Appraisal. Journal of Emergency Medicine, 37, 183-188. https://doi.org/10.1016/j.jemermed.2008.07.021
[5]
No Authors (2004) Etomidate Package Insert. Hospira, Inc., Lake Forest, IL.
[6]
Nestor, N.B. and Burton, J.H. (2008) ED Use of Etomidate for Rapid Sequence Induction. American Journal of Emergency Medicine, 26, 946-950.
https://doi.org/10.1016/j.ajem.2007.12.002
[7]
Edwin, S.B. and Walker, P.L. (2010) Controversies Surrounding the Use of Etomidate for Rapid Sequence Intubation in Patients with Suspected Sepsis. Annals of Pharmacotherapy, 44, 1307-1313. https://doi.org/10.1345/aph.1M664
[8]
Jung, B., Clavieras, N., Nougaret, S., et al. (2012) Effects of Etomidate on Complications Related to Intubation and on Mortality in Septic Shock Patients Treated with Hydrocortisone: A Propensity Score Analysis. Critical Care, 16, R224.
https://doi.org/10.1186/cc11871
[9]
Lundy, J.B., Slane, M.L. and Frizzi, J.D. (2007) Acute Adrenal Insufficiency after a Single Dose of Etomidate. Journal of Intensive Care Medicine, 22, 111-117.
https://doi.org/10.1177/0885066606298140
[10]
Hohl, C.M., Kelly-Smith, C.H., Yeung, T.C., et al. (2010) The Effect of a Bolus Dose of Etomidate on Cortisol Levels, Mortality, and Health Services Utilization: A Systematic Review. Annals of Emergency Medicine, 56, 105-113.
https://doi.org/10.1016/j.annemergmed.2010.01.030
[11]
Hildreth, A.N., Mejia, V.A., Maxwell, R.A., et al. (2008) Adrenal Suppression Following a Single Dose of Etomidate for Rapid Sequence Induction: A Prospective Randomized Study. The Journal of Trauma, 65, 573-579.
https://doi.org/10.1097/TA.0b013e31818255e8
[12]
Vinclair, M., Broux, C., Faure, P., et al. (2008) Duration of Adrenal Inhibition Following a Single Dose of Etomidate in Critically Ill Patients. Intensive Care Medicine, 34, 714-719. https://doi.org/10.1007/s00134-007-0970-y
[13]
Mohammad, Z., Afessa, B. and Finkielman, J.H. (2006) The Incidence of Relative Adrenal Insufficiency in Patients with Septic Shock after the Administration of Etomidate. Critical Care, 10, R105.
[14]
Mcphee, L.C., Badawi, O., Fraser, G.L., et al. (2013) Single-Dose Etomidate Is Not Associated with Increased Mortality in ICU Patients with Sepsis: Analysis of a Large Electronic ICU Database. Critical Care Medicine, 41, 774-783.
https://doi.org/10.1097/CCM.0b013e318274190d
[15]
No Authors (2009) Propofol Package Insert. APP Pharmaceuticals, LLC, Schaumburg.
[16]
Barr, J., Egan, T., Sandoval, N., et al. (2001) Propofol Dosing Regimens for ICU Sedation Based upon an Integrated Pharmacokinetic-Pharmacodynamic Model. Anesthesiology, 95, 324-333.
[17]
Black, E., Campbell, S.G., Magee, K. and Zed, P.J. (2013) Propofol for Procedural Sedation in the Emergency Department: A Qualitative Systematic Review. Annals of Pharmacotherapy, 47, 856-868. https://doi.org/10.1345/aph.1R743
[18]
Patanwala, A.E., Christich, A.C., Jasiak, K.D., et al. (2013) Age-Related Difference in Propofol Dosing for Procedural Sedation in the Emergency Department. The Journal of Emergency Medicine, 7, 1-6.
